It is a business services private limited company based in Salem, Tamil Nadu, India, established in 2019.
2019 | Salem, Tamil Nadu, India | ActiveBageo Pharmaceuticals Private Limited, a active private limited company, was established on 24 January 2019 in Salem, Tamil Nadu, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999TZ2019PTC031589. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Chandran Sathishkumar (Director), Suriyan Chandrasekar (Director), Mohammed Abdul Salam Mohamed Abdul Rahim (Director). Past directors included Gunabalan Senthil Kumar. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Shop No: 6/10, Senthil Complex Chinnathiruppathy,Salem-636008, Salem, Tamil Nadu, 636008.
U74999TZ2019PTC031589
031589
24 January 2019
₹0.10 M
₹0.10 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Bageo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandran Sathishkumar | Director | 30 Nov 2021 | Current |
| Suriyan Chandrasekar | Director | 24 Jan 2019 | Current |
| Mohammed Abdul Salam Mohamed Abdul Rahim | Director | 24 Jan 2019 | Current |
| Balachandar Chinnasamy | Director | 24 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bageo Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Bageo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bageo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bageo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bageo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bageo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Bageo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Coimbatore. was documented.
Chandran Sathishkumar was appointed as a Director was appointed as a Director on 30 Nov 2021 & has been associated with this company since 4 years 26 days . was recorded as a recent event.
Progress on Suriyan Chandrasekar was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was documented.
Progress on Mohammed Abdul Salam Mohamed Abdul Rahim was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was documented.
Balachandar Chinnasamy was appointed as a Director was appointed as a Director on 24 Jan 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
The CIN of Bageo Pharmaceuticals Private Limited is U74999TZ2019PTC031589.
Bageo Pharmaceuticals Private Limited is headquartered at Shop No: 6/10, Senthil Complex Chinnathiruppathy,Salem-636008, Salem, Tamil Nadu, 636008.
Bageo Pharmaceuticals Private Limited was incorporated on 24 January 2019.
The current directors of Bageo Pharmaceuticals Private Limited are
The primary industry of Bageo Pharmaceuticals Private Limited is Business Services.
Bageo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bageo Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Bageo Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX